The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis

Silvia Morbelli, Javier Arbizu, Jan Booij, Ming Kai Chen, Gael Chetelat, Donna J. Cross, Mehdi Djekidel, Alexander Drzezga, Ozgul Ekmekcioglu, Valentina Garibotto, Swen Hesse, Kazunari Ishii, Lida Jafari Saraf, Adriaan A. Lammertsma, Ian Law, Dana Mathews, Satoshi Minoshima, Karina Mosci, Marco Pagani, Sabina PappataDaniel Hillel Silverman, Alberto Signore, Elsmarieke Van De Giessen, Victor Villemagne, Henryk Barthel, on behalf of the European Association of Nuclear Medicine (EANM) and of the Society of Nuclear Medicine and Molecular Imaging (SNMMI)

Research output: Contribution to journalEditorialAcademicpeer-review

Original languageEnglish
Pages (from-to)353-357
Number of pages5
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume44
Issue number3
DOIs
Publication statusPublished - 1 Mar 2017

Cite this

Morbelli, S., Arbizu, J., Booij, J., Chen, M. K., Chetelat, G., Cross, D. J., ... on behalf of the European Association of Nuclear Medicine (EANM) and of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) (2017). The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis. European Journal of Nuclear Medicine and Molecular Imaging, 44(3), 353-357. https://doi.org/10.1007/s00259-016-3589-9